Abstract:Many diseases, as well as side effects of drugs, manifest themselves through skin symptoms. Skin is a complex tissue that hosts various specialized cell types and performs many roles including physical barrier, immune and sensory functions. Therefore, modeling skin in vitro presents technical challenges for tissue engineering. Since the first attempts at engineering human epidermis in 1970s, there has been a growing interest in generating full-thickness skin constructs mimicking physiological functions by incorporating various skin components, such as vasculature and melanocytes for pigmentation. Development of biomimetic in vitro human skin models with these physiological functions provides a new tool for drug discovery, disease modeling, regenerative medicine and basic research for skin biology. This goal, however, has long been delayed by the limited availability of different cell types, the challenges in establishing co-culture conditions, and the ability to recapitulate the 3D anatomy of the skin. Recent breakthroughs in induced pluripotent stem cell (iPSC) technology and microfabrication techniques such as 3D-printing have allowed for building more reliable and complex in vitro skin models for pharmaceutical screening. In this review, we focus on the current developments and prevailing challenges in generating skin constructs with vasculature, skin appendages such as hair follicles, pigmentation, immune response, innervation, and hypodermis. Furthermore, we discuss the promising advances that iPSC technology offers in order to generate in vitro models of genetic skin diseases, such as epidermolysis bullosa and psoriasis. We also discuss how future integration of the next generation human skin constructs onto microfluidic platforms along with other tissues could revolutionize the early stages of drug development by creating reliable evaluation of patient-specific effects of pharmaceutical agents. Impact statement Skin is a complex tissue that hosts various specialized cell types and performs many roles including barrier, immune, and sensory functions. For human-relevant drug testing, there has been a growing interest in building more physiological skin constructs by incorporating different skin components, such as vasculature, appendages, pigment, innervation, and adipose tissue. This paper provides an overview of the strategies to build complex human skin constructs that can faithfully recapitulate human skin and thus can be used in drug development targeting skin diseases. In particular, we discuss recent developments and remaining challenges in incorporating various skin components, availability of iPSC-derived skin cell types and in vitro skin disease models. In addition, we provide insights on the future integration of these complex skin models with other organs on microfluidic platforms as well as potential readout technologies for high-throughput drug screening.

3D Bioprinted Human Skin Model Recapitulating Native‐like Tissue Maturation and Immunocompetence as an Advanced Platform for Skin Sensitization Assessment

Three-dimensional Bioprinting of a Full-Thickness Functional Skin Model Using Acellular Dermal Matrix and Gelatin Methacrylamide Bioink

A biofabricated vascularized skin model of atopic dermatitis for preclinical studies

The development of a 3D immunocompetent model of human skin

3D Cell Printing of Perfusable Vascularized Human Skin Equivalent Composed of Epidermis, Dermis, and Hypodermis for Better Structural Recapitulation of Native Skin

3D Bioprinting a Novel Skin Co‐Culture Model Using Human Keratinocytes and Fibroblasts

Simple and robust 3D bioprinting of full-thickness human skin tissue

Direct 3D cell-printing of human skin with functional transwell system

3D bioprinting of skin tissue: From pre-processing to final product evaluation

3D Cell Printing of in Vitro Stabilized Skin Model and in Vivo Pre-Vascularized Skin Patch Using Tissue-Specific Extracellular Matrix Bioink: A Step Towards Advanced Skin Tissue Engineering

Utilization of patterned bioprinting for heterogeneous and physiologically representative reconstructed epidermal skin models

Fibrinogen-Based Bioink for Application in Skin Equivalent 3D Bioprinting

Next generation human skin constructs as advanced tools for drug development

Engineered-Skin of Single Dermal Layer Containing Printed Hybrid Gelatin-Polyvinyl Alcohol Bioink via 3D-Bioprinting: In Vitro Assessment under Submerged vs. Air-Lifting Models

Approaches to the development of 3d bioprinted skin models: the case of natura cosmetics

Advances in tissue engineering and biofabrication for in vitro skin modeling

Bioprinted autologous human skin equivalents for in vitro testing of therapeutic antibodies

A review of biomacromolecule-based 3D bioprinting strategies for structure-function integrated repair of skin tissues

3D bioprinting of skin: a state-of-the-art review on modelling, materials, and processes

Proof-of-concept: 3D bioprinting of pigmented human skin constructs

Development of immunocompetent full thickness skin tissue constructs to model skin fibrosis for high-throughput drug screening